BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Romero-Garcia S, Prado-Garcia H, Carlos-Reyes A. Role of DNA Methylation in the Resistance to Therapy in Solid Tumors. Front Oncol 2020;10:1152. [PMID: 32850327 DOI: 10.3389/fonc.2020.01152] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]
Number Citing Articles
1 Saadatpour F, Mohammadipanah F, Zohourian N, Hodjat M. Potential of nanoparticles and nanopolymers in treatment of age-associated diseases. Adv Nat Sci: Nanosci Nanotechnol 2022;12:045008. [DOI: 10.1088/2043-6262/ac42c7] [Reference Citation Analysis]
2 Wang J, Liu Y, Zhang S. Prognostic and immunological value of ATP6AP1 in breast cancer: implications for SARS-CoV-2. Aging (Albany NY) 2021;13:16904-21. [PMID: 34228637 DOI: 10.18632/aging.203229] [Reference Citation Analysis]
3 Oliver J, Garcia-Aranda M, Chaves P, Alba E, Cobo-Dols M, Onieva JL, Barragan I. Emerging noninvasive methylation biomarkers of cancer prognosis and drug response prediction. Semin Cancer Biol 2021:S1044-579X(21)00062-6. [PMID: 33757849 DOI: 10.1016/j.semcancer.2021.03.012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Zhou Y, Wang S, Yin X, Gao G, Wang Q, Zhi Q, Han Y, Kuang Y. TSHZ3 functions as a tumor suppressor by DNA methylation in colorectal cancer. Clin Res Hepatol Gastroenterol 2021;45:101725. [PMID: 34089916 DOI: 10.1016/j.clinre.2021.101725] [Reference Citation Analysis]
5 Kretzmann JA, Irving KL, Smith NM, Evans CW. Modulating gene expression in breast cancer via DNA secondary structure and the CRISPR toolbox. NAR Cancer 2021;3:zcab048. [PMID: 34988459 DOI: 10.1093/narcan/zcab048] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
6 Zhu L, Li X, Yuan Y, Dong C, Yang M. APC Promoter Methylation in Gastrointestinal Cancer. Front Oncol 2021;11:653222. [PMID: 33968756 DOI: 10.3389/fonc.2021.653222] [Reference Citation Analysis]
7 Mohamed Sa'dom SAF, Raikundalia S, Shamsuddin S, See Too WC, Few LL. DNA Methylation of Human Choline Kinase Alpha Promoter-Associated CpG Islands in MCF-7 Cells. Genes (Basel) 2021;12:853. [PMID: 34205960 DOI: 10.3390/genes12060853] [Reference Citation Analysis]
8 Liu C, Xu Y, Liu X, Fu Y, Zhu K, Niu Z, Liu J, Qian C. Upregulation of LINC00511 expression by DNA hypomethylation promotes the progression of breast cancer. Gland Surg 2021;10:1418-30. [PMID: 33968693 DOI: 10.21037/gs-21-84] [Reference Citation Analysis]
9 Horvathova Kajabova V, Soltysova A, Demkova L, Plesnikova P, Lyskova D, Furdova A, Babal P, Smolkova B. KIT Expression Is Regulated by DNA Methylation in Uveal Melanoma Tumors. Int J Mol Sci 2021;22:10748. [PMID: 34639089 DOI: 10.3390/ijms221910748] [Reference Citation Analysis]
10 Su JQ, Lai PY, Hu PH, Hu JM, Chang PK, Chen CY, Wu JJ, Lin YJ, Sun CA, Yang T, Hsu CH, Lin HC, Chou YC. Differential DNA methylation analysis of SUMF2, ADAMTS5, and PXDN provides novel insights into colorectal cancer prognosis prediction in Taiwan. World J Gastroenterol 2022; 28(8): 825-839 [PMID: 35317099 DOI: 10.3748/wjg.v28.i8.825] [Cited by in CrossRef: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Guru SA, Sumi MP, Mir AR, Beg MMA, koner BC, Saxena A. Aberrant hydroxymethylation in promoter CpG regions of genes related to the cell cycle and apoptosis characterizes advanced chronic myeloid leukemia disease, poor imatinib respondents and poor survival. BMC Cancer 2022;22. [DOI: 10.1186/s12885-022-09481-9] [Reference Citation Analysis]
12 Ntzifa A, Londra D, Rampias T, Kotsakis A, Georgoulias V, Lianidou E. DNA Methylation Analysis in Plasma Cell-Free DNA and Paired CTCs of NSCLC Patients before and after Osimertinib Treatment. Cancers (Basel) 2021;13:5974. [PMID: 34885084 DOI: 10.3390/cancers13235974] [Reference Citation Analysis]
13 Swellam M, Saad EA, Sabry S, Denewer A, Abdel Malak C, Abouzid A. Alterations of PTEN and SMAD4 methylation in diagnosis of breast cancer: implications of methyl II PCR assay. J Genet Eng Biotechnol 2021;19:54. [PMID: 33825073 DOI: 10.1186/s43141-021-00154-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
14 Chan DW, Lam WY, Chen F, Yung MMH, Chan YS, Chan WS, He F, Liu SS, Chan KKL, Li B, Ngan HYS. Genome-wide DNA methylome analysis identifies methylation signatures associated with survival and drug resistance of ovarian cancers. Clin Epigenetics 2021;13:142. [PMID: 34294135 DOI: 10.1186/s13148-021-01130-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Shenoy US, Adiga D, Kabekkodu SP, Hunter KD, Radhakrishnan R. Molecular implications of HOX genes targeting multiple signaling pathways in cancer. Cell Biol Toxicol 2021. [PMID: 34617205 DOI: 10.1007/s10565-021-09657-2] [Reference Citation Analysis]
16 Xiang F, Zhu Z, Zhang M, Wang J, Chen Z, Li X, Zhang T, Gu Q, Wu R, Kang X. 3,3'-Diindolylmethane Enhances Paclitaxel Sensitivity by Suppressing DNMT1-Mediated KLF4 Methylation in Breast Cancer. Front Oncol 2021;11:627856. [PMID: 34150611 DOI: 10.3389/fonc.2021.627856] [Reference Citation Analysis]
17 Uddin MG, Fandy TE. DNA methylation inhibitors: Retrospective and perspective view. Adv Cancer Res 2021;152:205-23. [PMID: 34353438 DOI: 10.1016/bs.acr.2021.03.007] [Reference Citation Analysis]
18 Shnaider PV, Ivanova OM, Malyants IK, Anufrieva KS, Semenov IA, Pavlyukov MS, Lagarkova MA, Govorun VM, Shender VO. New Insights into Therapy-Induced Progression of Cancer. Int J Mol Sci 2020;21:E7872. [PMID: 33114182 DOI: 10.3390/ijms21217872] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
19 Weiss F, Lauffenburger D, Friedl P. Towards targeting of shared mechanisms of cancer metastasis and therapy resistance. Nat Rev Cancer 2022. [PMID: 35013601 DOI: 10.1038/s41568-021-00427-0] [Reference Citation Analysis]
20 Min Q, Wang Y, Wu Q, Li X, Teng H, Fan J, Cao Y, Fan P, Zhan Q. Genomic and epigenomic evolution of acquired resistance to combination therapy in esophageal squamous cell carcinoma. JCI Insight 2021;6:150203. [PMID: 34494553 DOI: 10.1172/jci.insight.150203] [Reference Citation Analysis]